Evidence map›Paper›PMID 10587355›Full record

ArticleThe Journal of experimental medicine1999

Extracellular signal-regulated kinase (ERK) activation by the pre-T cell receptor in developing thymocytes in vivo.

A M Michie, S Trop, D L Wiest, J C Zúñiga-Pflücker

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. TEC and MAPK Kinase Signalling Pathways in T helper (TJournal of clinical & cellular immunology · 2012
    Article
  7. Pre-TCR-induced beta-catenin facilitates traversal through beta-selection.Journal of immunology (Baltimore, Md. : 1950) · 2009
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Allelic exclusion and differentiation by protein kinase C-mediated signals in immature thymocytes.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

A M MichieDepartment of Immunology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
S Trop
D L Wiest
J C Zúñiga-Pflücker

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The first checkpoint in T cell development occurs between the CD4(-)CD8(-) and CD4(+)CD8(+) stages and is associated with formation of the pre-T cell receptor (TCR). The signaling mechanisms that drive this progression remain largely unknown. Here, we show that extracellular signal-regulated kinases (ERKs)-1/2 are activated upon engagement of the pre-TCR. Using a novel experimental system, we demonstrate that expression of the pre-TCR by developing thymocytes induces ERK-1/2 activation within the thymus. In addition, the activation of this pre-TCR signaling cascade is mediated through Lck. These findings directly link pre-TCR complex formation with specific downstream signaling components in vivo.

Indexed as

AnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesDNA-Binding ProteinsEnzyme ActivationGene Rearrangement, beta-Chain T-Cell Antigen ReceptorMiceMice, KnockoutMice, SCIDMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Mitogen-Activated Protein KinasesPhosphorylationReceptor-CD3 Complex, Antigen, T-CellReceptors, Antigen, T-CellSignal TransductionDNA-Binding ProteinsMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Mitogen-Activated Protein KinasesRag2 protein, mouseReceptor-CD3 Complex, Antigen, T-CellReceptors, Antigen, T-CellV(D)J recombination activating protein 2

Identifiers

PMID10587355
PMCPMC2195734

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.